STEPHANIE FORD: Open Payments
NPI 1811969744 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,485 in 104 payments from 9 companies in 2025. Trend: 2023 $2,156 · 2024 $2,577 · 2025 $2,485
Food & beverage: $2,485
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 34 | $747 |
| Neurocrine BioSciences, Inc. | 26 | $637 |
| Vanda Pharmaceuticals Inc. | 17 | $472 |
| Alkermes, Inc. | 11 | $192 |
| E.R. Squibb & Sons, L.L.C. | 5 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $183 |
| Luye Pharma (USA) Ltd. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: AUSTEDO XR, INGREZZA, HETLIOZ, COBENFY, CAPLYTA, ARISTADA, FANAPT, LYBALVI.
Industry payments across FL — which companies pay providers there.
